News from Dilon Technologies Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 25, 2016, 14:43 ET DILON Diagnostics and GE Healthcare announce the FDA clearance of the Discovery NM 750b biopsy accessory

DILON Diagnostics and GE Healthcare are pleased to announce the FDA clearance of the Molecular Breast Imaging (MBI) localization accessory for...


Jul 06, 2016, 15:57 ET Dilon Introduces the New Purple Navigator 2.0 Gamma Probe System

Dilon Technologies® Inc. a world leader in molecular detection medical devices recently introduced the new purple Navigator 2.0 gamma probe...


Jul 10, 2014, 22:19 ET Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem

 Dilon Technologies, ein führender Hersteller von Kameras für die molekulare Bildgebung, einschließlich molekularer Bildgebung...


Jul 10, 2014, 22:06 ET Dilon reçoit le marquage d'attestation CE pour son système de sonde gamma Navigator Gamma Probe System

 Dilon Technologies, société leader dans le domaine des caméras d'imagerie moléculaire, notamment de l'imagerie...


Jul 10, 2014, 10:44 ET Dilon receives CE Mark Approval for its Navigator Gamma Probe System

 Dilon Technologies, leader in molecular imaging cameras including Molecular Breast Imaging (MBI/BSGI), announced today that it obtained CE...


Jun 02, 2014, 11:48 ET Determined Patient Wins Legal Fight to Cover Molecular Breast Imaging Procedure

When a health insurance company denies a claim, most people complain to their friends and family and then accept it, arranging payment methods or...


Jan 06, 2014, 10:17 ET Dilon Acquires RMD Navigator Gamma Probes

NEWPORT NEWS, Va., Jan. 6, 2014 /PRNewswire/ --  Dilon Technologies Inc. announced today that they acquired the assets of the Navigator gamma...


May 01, 2013, 10:47 ET Researchers Determine Molecular Breast Imaging to be a Useful Adjunct to Mammography

 Molecular breast imaging (MBI), also known as breast-specific gamma imaging (BSGI), is a relatively new form of breast cancer detection...


Nov 29, 2012, 18:13 ET Researchers at RSNA Determine Molecular Breast Imaging Improves Early Detection in High-Risk Women

The Radiological Society of North America (RSNA) Meeting, held annually in Chicago, Illinois, is one of the largest and most prestigious medical...


Oct 26, 2012, 11:15 ET Low-Dose Molecular Breast Imaging Marks a New Frontier in the Fight Against Breast Cancer

Molecular Breast Imaging (MBI), also known as Breast-Specific Gamma Imaging (BSGI), is a procedure that is able to detect breast cancers missed...


Aug 15, 2012, 11:00 ET New Data Suggests Low-Dose Molecular Breast Imaging is Possible for Single-Head Imaging Systems

 Molecular Breast Imaging (MBI), also known as Breast-Specific Gamma Imaging (BSGI), is a breast imaging procedure performed using a tracer...


Jul 10, 2012, 17:29 ET BSGI Molecular Breast Imaging Proves Equivalent to MRI in Breast Cancer Patient Management

 According to a new study presented at the 2012 American Society of Breast Surgeons, Molecular Breast Imaging (MBI), also known as BSGI, is...


Jul 10, 2012, 15:30 ET BSGI Molecular Breast Imaging Provides Better Results than MRI for Cancer Patients with Dense Breasts

According to a new study by Korean researchers at the Ewha Women's Hospital in Seoul, published this year in the Annals of Nuclear...


May 09, 2012, 09:00 ET 3D Imaging in the Operating Room is set to Revolutionize Radio-Guided Surgeries

For decades, non-imaging gamma probes have been used to guide surgeons to critical lymph nodes in cancer patients. More recently, a procedure has...


Mar 27, 2012, 07:13 ET Adding BSGI Molecular Breast Imaging to Breast Imaging Centers Significantly Improves Breast Cancer Detection

Dilon Diagnostics -- According to the results from a new multi-center patient registry, presented at the National Consortium of Breast Centers...


Feb 14, 2012, 08:00 ET Molecular Breast Imaging Is Superior to Ultrasound and Mammography for the Detection of Breast Cancer

Dilon Diagnostics -- According to a new study published in the American Journal of Roentgenology (AJR) in January 2012, Molecular Breast Imaging...


Nov 30, 2011, 08:00 ET BSGI/MBI Enhances Pre-Surgical Planning For Patients With Newly Diagnosed Breast Cancer

According to a new study, Breast-Specific Gamma Imaging (BSGI), also known as Molecular Breast Imaging (MBI), can provide critical information in...


Nov 30, 2011, 08:00 ET BSGI/MBI Proven to Be Equivalent to MRI in the Detection of Breast Cancer

Breast-Specific Gamma Imaging (BSGI), also known as Molecular Breast Imaging (MBI), has been found to be equivalent to Magnetic Resonance Imaging...


Nov 29, 2011, 08:00 ET BSGI/MBI Shows Greater Sensitivity and Comparable Specificity When Compared to Ultrasound and Mammography

When compared to mammography and ultrasound, Breast-Specific Gamma Imaging (BSGI), also known as Molecular Breast Imaging (MBI), has greater...


Nov 29, 2011, 08:00 ET BSGI/MBI: Effective for Detecting Breast Cancer In Dense and Non-Dense Breasts

 Unlike mammography, Breast-Specific Gamma Imaging (BSGI), also known as Molecular Breast Imaging (MBI), is as effective in detecting breast...


Sep 27, 2011, 08:00 ET Dilon Diagnostics® Signs Exclusive Distribution With SurgicEye®

Dilon Diagnostics®, the world leader in molecular breast imaging, and SurgicEye®, the leading provider of intraoperative soft tissue...


Aug 30, 2011, 09:04 ET Dilon Diagnostics® Partners With PenRad®

Dilon expands its portfolio of breast imaging solutions through a sales alliance with PenRad, rated #1 Mammography Information System technology by...


Jun 02, 2011, 08:00 ET The World Leader in Molecular Breast Imaging to Premiere Largest Detector in the Industry

Dilon Diagnostics will introduce the latest advancement in molecular breast imaging (MBI) this week at the Society of Nuclear Medicine (SNM)...


May 13, 2011, 08:00 ET Latest Clinical Evidence Supports Promising Outlook for Low-Dose Molecular Breast Imaging (MBI)

The possibility of low-dose Molecular Breast Imaging (MBI) looks promising according to the most recent clinical evidence revealed this past month...


Mar 31, 2011, 08:00 ET U.S. Department of Energy Hails Dilon Diagnostics as a Medical Technology Pioneer and Top National Innovator

The U.S. Department of Energy has acclaimed Dilon Diagnostics as a success story in the field of medical technology and innovation for...